New York State Common Retirement Fund Rocket Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
A detailed history of New York State Common Retirement Fund transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 15,117 shares of RCKT stock, worth $118,668. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,117
Previous 15,117
-0.0%
Holding current value
$118,668
Previous $190,000
46.84%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding RCKT
# of Institutions
243Shares Held
94.8MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$139 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$51.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$48.6 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$40.8 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$37 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $594M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...